Dr. Meneve K.: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Dr. Meneve K.
Largest movements
- Tangible fixed assets -€8,798
down €8,798 (-4.2%), from €211,062 to €202,263
- Cash +€4,809
up €4,809 (+18.4%), from €26,176 to €30,985
mainly Depreciation (+€8,798) and Accrued charges and deferred income (+€115)
- Reserves -€3,528
down €3,528 (-2.0%), from €173,233 to €169,704
- Gross operating margin +€6,934
up €6,934 (+2,510%), from €276 to €7,211
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €237,286 | €233,873 | -€3,413 | -1.4% |
| Fixed assets | 21/28 | €211,062 | €202,263 | -€8,798 | -4.2% |
| Tangible fixed assets | 22/27 | €211,062 | €202,263 | -€8,798 | -4.2% |
| Land and buildings | 22 | €211,062 | €202,263 | -€8,798 | -4.2% |
| Current assets | 29/58 | €26,225 | €31,610 | +€5,385 | +20.5% |
| Amounts receivable within one year | 40/41 | €49 | €624 | +€575 | +1,177% |
| Trade receivables | 40 | - | €578 | +€578 | |
| Other amounts receivable | 41 | €49 | €46 | -€3 | -5.1% |
| Cash at bank and in hand | 54/58 | €26,176 | €30,985 | +€4,809 | +18.4% |
| Total equity and liabilities | 10/49 | €237,286 | €233,873 | -€3,413 | -1.4% |
| Equity | 10/15 | €188,233 | €184,704 | -€3,528 | -1.9% |
| Contributions | 10/11 | €15,000 | €15,000 | = | 0.0% |
| Reserves | 13 | €173,233 | €169,704 | -€3,528 | -2.0% |
| Distributable reserves | 133 | €173,233 | €169,704 | -€3,528 | -2.0% |
| Amounts payable | 17/49 | €49,054 | €49,169 | +€115 | +0.2% |
| Amounts payable within one year | 42/48 | €47,904 | €47,904 | = | 0.0% |
| Trade debts | 44 | €309 | €309 | = | 0.0% |
| Suppliers | 440/4 | €309 | €309 | = | 0.0% |
| Other amounts payable | 47/48 | €47,596 | €47,596 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €1,150 | €1,264 | +€115 | +10.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €8,798 | €8,798 | = | 0.0% |
| Other operating charges | 640/8 | €1,961 | €2,022 | +€60 | +3.1% |
| Gross operating margin | 9900 | €276 | €7,211 | +€6,934 | +2,510% |
| Operating profit (loss) | 9901 | -€10,483 | -€3,610 | +€6,874 | +65.6% |
| Financial income | 75/76B | €163 | €155 | -€8 | -5.1% |
| Recurring financial income | 75 | €163 | €155 | -€8 | -5.1% |
| Financial charges | 65/66B | €69 | €74 | +€5 | +6.5% |
| Recurring financial charges | 65 | €69 | €74 | +€5 | +6.5% |
| Profit (loss) for the period before taxes | 9903 | -€10,389 | -€3,528 | +€6,861 | +66.0% |
| Income taxes | 67/77 | €0 | €0 | = | |
| Profit (loss) for the period | 9904 | -€10,389 | -€3,528 | +€6,861 | +66.0% |
| Profit (loss) for the period to be appropriated | 9905 | -€10,389 | -€3,528 | +€6,861 | +66.0% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.